Pharmaceuticals

Shandong Shengli Bioengineering Co., Ltd is a joint venture built by China Animal Husbandry Industry Co., Ltd and Shandong Shengli Co., Ltd. We are national high-tech enterprise, and mainly producing animal-specific antibiotic API, veterinary preparations and feed additives, such as Tiamulin Fumarate, Enramycin, Bambermycin, Nosiheptide, and Monensin, etc. Shengli strictly follows the current GMP regulations in Europe and the United States, establishes a sound quality management system, and has passed ISO9001, ISO14001, ISO45001 certification, and the US FDA site audit with "0-483". Tiamulin Fumarate API is the first to obtain the EU COS Certificate in China, Enramycin is the first to obtain Production and Sale Certificate domestically. Based in China, with a global business strategy, the company has built a global marketing network.

As one of the main pharmaceutical manufacturing enterprises of Fosun Pharma, Guilin Pharma, established in 1950's, is a subsidiary company of Fosun Pharma Group that produces more than 2000 chemical medicines in different dosage forms such as tablets, capsules and injections. As the first Chinese pharmaceutical manufacturer approved by the World Health Organization, Guilin Pharma is also China's largest artemisinin based anti-malarial drug producer with the world's most integrated artemisinin industry value chain. So far, products of Guilin Pharma have been registered and marketed in more than 30 countries internationally. As a World Health Organization approved antimalatial producer, Guilin Pharma has supplied over 20,0000,000 oral treatments of its artemisinin based antimalarial drugs to the world malaria campaign Guilin Pharma also works with international NG0s, academic institutions and local malaria control programs on training project to improve the skills of local medical staff so as to reduce malaria in African children. Guilin Pharma believes in a management philosophy of quality comes first. It continuously improves its production process with international Good manufacturing Practiices standards so as to supply high quality pharmaceuticals to people who use its products.

Livzon is a comprehensive pharmaceutical enterprise integrating development & research, production and sales of pharmaceutical products, ranking 9 at Top 50 Pharmaceutical companies in China, ranking 8 at Top 10 listed pharmaceutical companies with the highest R&D investment. Livzon Group API Division established June 2015, is dedicated in the R&D, manufacturing and sales of API, including 4 manufacturing sites, Livzon Fuzhou Fuxing, Livzon New North River, Livzon Ningxia and Livzon Syntpharm. Most of the manufacturing sites have been approved by US FDA. And most of the products in regulatory markets have obtained CEP.